---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-240034"
form_type: "8-K"
ticker: "FNCHQ"
cik: "0001733257"
company_name: "Finch Therapeutics Group, Inc."
filed_at: "2024-10-21T23:59:59+00:00"
generated_at: "2026-05-30T12:22:47.754176+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Finch Therapeutics initiates Nasdaq delisting; plans SEC deregistration by Nov 11

## Summary
- Board determined to delist common stock from Nasdaq; Form 25 to be filed on or about Oct 31, 2024.
- Delisting effective 10 days after Form 25 filing; trading to continue on OTC Markets Group.
- Form 15 to be filed on or about Nov 11, 2024 to deregister under Exchange Act; reporting obligations suspended immediately.
- Board cites cost savings from SEC reporting, Sarbanes-Oxley compliance, and prior non-compliance (public shell, market value deficiency).
- Common stock suspended from Nasdaq since May 28, 2024 due to Nasdaq's public shell determination.

## SEC filing metadata
- accession: 0001193125-24-240034
- form_type: 8-K
- ticker: FNCHQ
- cik: 0001733257
- company_name: Finch Therapeutics Group, Inc.
- filed_at: 2024-10-21T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1733257/000119312524240034/0001193125-24-240034-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1733257/000119312524240034/d881100d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-240034
- JSON: https://secwatch.observer/filing/0001193125-24-240034.json
- Plain text: https://secwatch.observer/filing/0001193125-24-240034.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.